Importance of diagnosis-to-treatment interval in newly diagnosed patients with diffuse large B-cell lymphoma
Abstract Treatment of patients with malignancy sometimes be delayed due to various reasons. Several studies revealed that an influence of diagnosis-to-treatment interval (DTI) on outcomes differs depending on the type of malignancy. In this study, we evaluated the influence of DTI on clinical outcom...
Guardado en:
Autores principales: | Masahiro Yoshida, Yosuke Nakaya, Katsujun Shimizu, Naoko Tatsumi, Minako Tsutsumi, Hoyuri Fuseya, Mirei Horiuchi, Takuro Yoshimura, Yoshiki Hayashi, Takafumi Nakao, Takeshi Inoue, Takahisa Yamane |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4bc35587960143248af35001577f9702 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia
por: Judith E Karp, et al.
Publicado: (2008) -
Newly Diagnosed Atrial Fibrillation in Acute Myocardial Infarction
por: Yuki Obayashi, et al.
Publicado: (2021) -
Childhood tuberculosis in household contacts of newly diagnosed TB patients.
por: Srichand Batra, et al.
Publicado: (2012) -
Treatment outcome among newly diagnosed tuberculosis patients in Kenya
por: Dennis Magu, et al.
Publicado: (2016) -
HOW I TREAT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS?
por: María-Victoria Mateos
Publicado: (2021)